Ad Scientiam
PrivateLast Round
VC Round
Nov 5, 2023
Company Overview
Ad Scientiam is a digital health company that develops and validates digital biomarkers for the continuous monitoring of severe and debilitating chronic diseases.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials, Medical AI, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Ad Scientiam Comparables
Compare Ad Scientiam with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Altoida, Inc. | 87% | |
| Koneksa Health | 83% | |
| Neurotrack Technologies, Inc. | 78% |
Ad Scientiam Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| VC Round | Nov 5, 2023 | ||||
| VC Round | Jul 13, 2017 |
Ad Scientiam Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| TechLife Capital | VC Round |
| Bpifrance | VC Round |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 31, 2026
Monthly visitors grew 165% MoM, reaching 961.
- Nov 5, 2023
$5.4M round led by TechLife Capital
Ad Scientiam Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Ad Scientiam's valuation, stock price, and market status.
Is Ad Scientiam a public or private company?
Ad Scientiam is a private company.
What is the current stock price of Ad Scientiam?
Ad Scientiam is a private company with no public stock price. No recent secondary market data is available.
How much is Ad Scientiam worth (valuation)?
Valuation information for Ad Scientiam is not publicly available.
Can I buy Ad Scientiam stock?
Ad Scientiam shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Ad Scientiam's last funding round?
Ad Scientiam's most recent funding round was VC Round on November 5, 2023.
Who are the main investors in Ad Scientiam?
Key investors in Ad Scientiam include TechLife Capital.
Will Ad Scientiam IPO soon?
No public IPO plans have been announced for Ad Scientiam.
How can I track Ad Scientiam secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Ad Scientiam's secondary market activity and sign up for updates.